Literature DB >> 21884138

The treatment of oral cancer: an overview for dental professionals.

H Deng1, P J Sambrook, R M Logan.   

Abstract

Oral cancer is a serious life-threatening disease. Dental professionals may be the first individuals to identify/suspect these lesions before referring to oral and maxillofacial surgeons and oral medicine specialists. Because the general dentist will likely follow on with the patient's future oral health, it is important that he or she has a basic understanding of the various treatments involved in treating oral malignancies and their respective outcomes. The four main modalities discussed in this review include surgery alone, radiotherapy alone, surgery with radiotherapy, and chemotherapy with or without surgery and radiotherapy. Chemotherapy has become an area of great interest with the introduction of new 'targeted therapies' demonstrating promising results in conjunction with surgery. Despite these results, the toxicities associated with chemotherapy regimens are frequent and can be severe, and therefore may not be suitable for all patients. Treatment modalities have improved significantly over the decades with overall decreases in recurrence rates, improved disease-free and overall survival, and an improved quality of life. Prognosis, however, is still ultimately dependent on the clinical stage of the tumour at the initial diagnosis with respect to size, depth, extent, and metastasis as recurrence rates and survival rates plummet with disease progression.
© 2011 Australian Dental Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21884138     DOI: 10.1111/j.1834-7819.2011.01349.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  9 in total

1.  Overexpression of ADAM9 in oral squamous cell carcinoma.

Authors:  Pattaramon Tanasubsinn; Win Pa Pa Aung; Supansa Pata; Witida Laopajon; Anupong Makeudom; Thanapat Sastraruji; Watchara Kasinrerk; Suttichai Krisanaprakornkit
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

2.  Self-perception versus professional assessment of functional outcome after ablative surgery in patients with oral cancer.

Authors:  Benedicta E Beck-Broichsitter; Jörn Huck; Thomas Küchler; Daniela Hauke; Jürgen Hedderich; Jörg Wiltfang; Stephan T Becker
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-18       Impact factor: 4.553

Review 3.  Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.

Authors:  Kelvin K W Chan; Anne-Marie Glenny; Jo C Weldon; Susan Furness; Helen V Worthington; Helen Wakeford
Journal:  Cochrane Database Syst Rev       Date:  2015-12-01

4.  Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.

Authors:  Jhon A Ochoa-Alvarez; Harini Krishnan; John G Pastorino; Evan Nevel; David Kephart; Joseph J Lee; Edward P Retzbach; Yongquan Shen; Mahnaz Fatahzadeh; Soly Baredes; Evelyne Kalyoussef; Masaru Honma; Martin E Adelson; Mika K Kaneko; Yukinari Kato; Mary Ann Young; Lisa Deluca-Rapone; Alan J Shienbaum; Kingsley Yin; Lasse D Jensen; Gary S Goldberg
Journal:  Oncotarget       Date:  2015-04-20

5.  Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential.

Authors:  Bok Hee Woo; Da Jeong Kim; Jeom Il Choi; Sung Jo Kim; Bong Soo Park; Jae Min Song; Ji Hye Lee; Hae Ryoun Park
Journal:  Oncotarget       Date:  2017-07-18

6.  CAD-CAM Hollow Obturator Prosthesis: A Technical Report.

Authors:  Amal Alfaraj; Fang-Yu Su; Wei-Shao Lin
Journal:  J Prosthodont       Date:  2022-04-11       Impact factor: 3.485

7.  Survival of patients with oral cavity cancer in Germany.

Authors:  Stefan Listl; Lina Jansen; Albrecht Stenzinger; Kolja Freier; Katharina Emrich; Bernd Holleczek; Alexander Katalinic; Adam Gondos; Hermann Brenner
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

8.  High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials.

Authors:  Zhenxing Liu; Shengyun Huang; Dongsheng Zhang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

9.  Histopathological grading systems analysis of oral squamous cell carcinomas of young patients.

Authors:  J-C Frare; I Sawazaki-Calone; A-L-C Ayroza-Rangel; A-G Bueno; C-F de Morais; H-M Nagai; R Kunz; M-A Lopes
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.